Phenobarbital in super-refractory status epilepticus (PIRATE): A retrospective, multicenter analysis

Kunst S, Rojo ML, Schmidbauer MO, Pelz J, Mueller A, Minnerup J, Meyer L, Madžar D, Reindl C, Madlener M, Malter M, Neumann B, Dimitriadis K (2023)

Publication Type: Journal article

Publication year: 2023

Journal

Epilepsia Wiley-Blackwell

DOI: 10.1111/epi.17608

Abstract

Objective: Super-refractory status epilepticus (SRSE) is an enduring or recurring SE after 24 h or more of general anesthesia. This study aimed to evaluate the efficacy and safety of phenobarbital (PB) for the treatment of SRSE.

Authors with CRIS profile

Dominik Madzar Lehrstuhl für Neurologie Caroline Reindl Department of Neurology

Additional Organisation(s)

FAU Profilzentrum Licht.Materie.Quantentechnologien (FAU LMQ)

Involved external institutions

Ludwig-Maximilians-Universität (LMU) DE Germany (DE) Westfälische Wilhelms-Universität (WWU) Münster DE Germany (DE) Universität zu Köln DE Germany (DE) Universität Regensburg DE Germany (DE) Universitätsklinikum Leipzig DE Germany (DE)

How to cite

APA:

Kunst, S., Rojo, M.L., Schmidbauer, M.O., Pelz, J., Mueller, A., Minnerup, J.,... Dimitriadis, K. (2023). Phenobarbital in super-refractory status epilepticus (PIRATE): A retrospective, multicenter analysis. Epilepsia. https://dx.doi.org/10.1111/epi.17608

MLA:

Kunst, Stefan, et al. "Phenobarbital in super-refractory status epilepticus (PIRATE): A retrospective, multicenter analysis." Epilepsia (2023).

BibTeX: Download